<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966924</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-0007</org_study_id>
    <nct_id>NCT03966924</nct_id>
  </id_info>
  <brief_title>The PREFORM Study: A Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring</brief_title>
  <official_title>The PREFORM Study: An Exploratory, Single-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring and Optimal Peri-Procedure Regimen for Accelerated Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Recros Medica, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Recros Medica, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, single-arm (non-randomized), interventional cohort,
      non-significant risk (NSR) study designed to investigate the efficacy and safety of
      Rotational Fractional Resection (skin resection and focal lipectomy) in patients with
      moderate to severe submental skin laxity. The total duration of study participation for each
      subject is approximately up to 4 months for each subject from the screening visit to the exit
      visit. The follow-up period will be approximately 3 months after the procedure. Eligible
      subjects will complete a total of 11 study visits: screening, procedure, and follow-up visits
      at 1, 4, 7, 14, 21, 30, 45, 60, and 90 days post-procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Actual">October 16, 2019</completion_date>
  <primary_completion_date type="Actual">October 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved Skin Laxity</measure>
    <time_frame>Change from Baseline to 90 days after treatment</time_frame>
    <description>Comparison of the submentum before and after procedure using the Submental Skin Laxity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improved Skin Lipodystrophy</measure>
    <time_frame>Change from Baseline to 90 days after treatment</time_frame>
    <description>Comparison of the submentum before and after procedure using the Submental Skin Lipodystrophy scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subject Satisfaction: Subject Satisfaction Questionnaire</measure>
    <time_frame>90 days after treatment</time_frame>
    <description>Subject satisfaction of the procedure as assessed using the Subject Satisfaction Questionnaire</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Skin Laxity</condition>
  <condition>Lipodystrophy</condition>
  <arm_group>
    <arm_group_label>Rotational fractional resection (RFR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Focal Contouring System</intervention_name>
    <description>Single treatment of skin resection and possibly focal lipectomy (removal of loose skin and fat)</description>
    <arm_group_label>Rotational fractional resection (RFR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female

          -  At least 30 years old

          -  Moderate to severe submental laxity

          -  Up to moderate submental lipodystrophy

          -  Agree to maintain weight (Â±5%) for the duration of the study

        Exclusion Criteria:

        Previous intervention to treat submental fat or skin laxity

          -  Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure

          -  Severe acne, cystic acne or acne scars on neck

          -  Trauma of chin or neck area

          -  Skin infection or rash on neck

          -  Psoriasis, hyperpigmentation, eczema, rosacea or vitiligo

          -  History of scarring

          -  Body mass index (BMI) &gt;30

          -  Clinically significant bleeding disorder

          -  Anemia, kidney disease, or liver disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Steve Yoelin, MD Medical Associates, Inc.</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 19, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>submental</keyword>
  <keyword>laxity</keyword>
  <keyword>lipodystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

